Pharma News - M&A/Partnerships News & Articles

801 Bayer HealthCare Marks Opening of U.S. Innovation Center Full Text Bayer HealthCare Pharmaceuticals, January 11, 2011

802 Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C Full Text Bristol Myers-Squibb, January 11, 2011

803 KINAXO Enters Agreement with AstraZeneca B3C newswire, January 6, 2011

804 Hitachi signs agreement with Horizon Medical Full Text Canadian Healthcare Technology, January 5, 2011

805 Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. Abbott, January 3, 2011

806 EpiTherapeutics and Abbott Enter into Oncology Collaboration on Epigenetic Targets Abbott, January 3, 2011

807 Abbott and AstraZeneca End License Agreement for the Development of CERTRIAD Abbott, January 3, 2011

808 Abbott and AstraZeneca End License Agreement for the Development of CERTRIAD Abbott, December 23, 2010

809 Norton Healthcare and Humana to Form an ACO Health Data Management, December 23, 2010

810 Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery Technology in Diabetes and Related Disorders Full Text Sanofi, December 22, 2010

811 Teva and Takeda Settle Generic ACTOS and ACTOplus met Litigation Full Text Teva Pharmaceutical Industries, December 22, 2010

812 Biogen Idec and Neurimmune Announce Agreement on Three Neurodegenerative Disease Programs B3C newswire, December 22, 2010

813 EpiTherapeutics and Abbott Enter into Oncology Collaboration on Epigenetic Targets Abbott, December 21, 2010

814 Bristol-Myers Squibb and Oncolys BioPharma Enter Global Licensing Agreement for Investigational HIV Compound Full Text Bristol Myers-Squibb, December 21, 2010

815 Sanofi-aventis and Merck KGaA Sign Agreement to Jointly Investigate Novel Combinations Against Cancer Full Text Sanofi, December 20, 2010

816 Public-Private Partnerships: Life-Saving Mechanisms of Action Full Text BioPharm International, December 17, 2010

817 Watson and Richter Announce Exclusive License Agreement for Esmya Full Text Actavis, December 17, 2010

818 Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis Full Text Lundbeck, December 17, 2010

819 Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools Full Text Amgen, December 17, 2010

820 Bayer MaterialScience and Asklepios cooperate on sustainable and cost-effective solutions for hospitals Full Text BayNews International, December 17, 2010

1 Sanofi strengthens its French-German partnership on the occasion the French-German Week for Science and Alumni Sanofi, April 16, 2013    Free full text

2 Actavis and Valeant Announce Actavis as Exclusive Authorized Generic Marketer of Zovirax Ointment; Co-Promotion Agreements on Zovirax Cream and Cordran Tape Valeant Pharmaceuticals International, April 8, 2013    Free full text

3 Actavis Announces OxyContin Patent Challenge Settlement Actavis, May 1, 2013    Free full text

4 Actavis Reaches Agreements with Valeant to Launch Generic Versions of Ziana and Zyclara Valeant Pharmaceuticals International, April 11, 2013    Free full text

5 Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation Bristol Myers-Squibb, May 10, 2013    Free full text

6 Novartis wins GBCHealth Business Action on Health Award for social ventures initiative Novartis, May 20, 2013    Free full text

7 Actavis to acquire warner chilcott BioPharm International, May 29, 2013    Free full text

8 Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel Valeant Pharmaceuticals International, May 2, 2013    Free full text